HEADER ISOMERASE 27-OCT-02 1O79 TITLE STRUCTURES OF HUMAN OXIDOSQUALENE CYCLASE INHIBITORS BOUND TO AN TITLE 2 HOMOLOGOUS ENZYME COMPND MOL_ID: 1; COMPND 2 MOLECULE: SQUALENE--HOPENE CYCLASE; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: SHC; COMPND 5 EC: 5.4.99.17; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ALICYCLOBACILLUS ACIDOCALDARIUS; SOURCE 3 ORGANISM_TAXID: 405212; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI K-12; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 83333; SOURCE 6 EXPRESSION_SYSTEM_VARIANT: JM105; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PKK223-3; SOURCE 9 OTHER_DETAILS: THERMOSTABLE, ACIDOPHILIC KEYWDS ISOMERASE, CHOLESTEROL BIOSYNTHESIS, INHIBITOR, MONOTOPIC MEMBRANE KEYWDS 2 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR A.LENHART,D.J.REINERT,W.A.WEIHOFEN,J.D.AEBI,H.DEHMLOW,O.H.MORAND, AUTHOR 2 G.E.SCHULZ REVDAT 5 08-MAY-24 1O79 1 REMARK REVDAT 4 20-JUN-18 1O79 1 TITLE REVDAT 3 20-NOV-13 1O79 1 COMPND SOURCE KEYWDS REMARK REVDAT 3 2 1 VERSN FORMUL REVDAT 2 24-FEB-09 1O79 1 VERSN REVDAT 1 23-OCT-03 1O79 0 JRNL AUTH A.LENHART,D.J.REINERT,J.D.AEBI,H.DEHMLOW,O.H.MORAND, JRNL AUTH 2 G.E.SCHULZ JRNL TITL BINDING STRUCTURES AND POTENCIES OF OXIDOSQUALENE CYCLASE JRNL TITL 2 INHIBITORS WITH THE HOMOLOGOUS SQUALENE-HOPENE CYCLASE JRNL REF J.MED.CHEM. V. 46 2083 2003 JRNL REFN ISSN 0022-2623 JRNL PMID 12747780 JRNL DOI 10.1021/JM0211218 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.LENHART,W.A.WEIHOFEN,A.E.W.PLESCHKE,G.E.SCHULZ REMARK 1 TITL CRYSTAL STRUCTURE OF A SQUALENE CYCLASE IN COMPLEX WITH THE REMARK 1 TITL 2 POTENTIAL ANTICHOLESTEREMIC DRUG RO48-8071 REMARK 1 REF CHEM.BIOL. V. 9 639 2002 REMARK 1 REFN ISSN 1074-5521 REMARK 1 PMID 12031670 REMARK 1 DOI 10.1016/S1074-5521(02)00138-2 REMARK 1 REFERENCE 2 REMARK 1 AUTH K.U.WENDT,A.LENHART,G.E.SCHULZ REMARK 1 TITL THE STRUCTURE OF THE MEMBRANE PROTEIN SQUALENE-HOPENE REMARK 1 TITL 2 CYCLASE AT 2.0 A RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 286 175 1999 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 9931258 REMARK 1 DOI 10.1006/JMBI.1998.2470 REMARK 1 REFERENCE 3 REMARK 1 AUTH K.U.WENDT,K.PORALLA,G.E.SCHULZ REMARK 1 TITL STRUCTURE AND FUNCTION OF A SQUALENE CYCLASE REMARK 1 REF SCIENCE V. 277 1811 1997 REMARK 1 REFN ISSN 0036-8075 REMARK 1 PMID 9295270 REMARK 1 DOI 10.1126/SCIENCE.277.5333.1811 REMARK 1 REFERENCE 4 REMARK 1 AUTH O.H.MORAND,J.D.AEBI,H.DEHMLOW,Y.H.JI,N.GAINS,H.LENGSFELD, REMARK 1 AUTH 2 J.HIMBER REMARK 1 TITL RO48-8071, A NEW 2,3-OXIDOSQUALENE:LANOSTEROL CYCLASE REMARK 1 TITL 2 INHIBITOR LOWERING PLASMA CHOLESTEROL IN HAMSTERS, SQUIRREL REMARK 1 TITL 3 MONKEYS, AND MINIPIGS: COMPARISON TO SIMVASTATIN REMARK 1 REF J.LIPID RES. V. 38 373 1997 REMARK 1 REFN ISSN 0022-2275 REMARK 1 PMID 9162756 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 74.2 REMARK 3 NUMBER OF REFLECTIONS : 52186 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.239 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 14892 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 156 REMARK 3 SOLVENT ATOMS : 237 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.100 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : RESTRAINTS REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1O79 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 27-OCT-02. REMARK 100 THE DEPOSITION ID IS D_1290011613. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 298.0 REMARK 200 PH : 4.80 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200B REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : SIEMENS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 54923 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 43.030 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 79.4 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.13700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 4.80 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 163.59800 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 81.79900 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 81.79900 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 163.59800 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 70.64450 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 122.35986 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 163.59800 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 141.28900 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 163.59800 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 211.93350 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 122.35986 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 163.59800 REMARK 400 REMARK 400 COMPOUND REMARK 400 CATALYZES CYCLIZATION OF SQUALENE TO HOPENE. REMARK 400 KEY ENZYME IN HOPANOID (TRITERPENOID) METABOLISM. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 GLU A 3 REMARK 465 GLN A 4 REMARK 465 LEU A 5 REMARK 465 VAL A 6 REMARK 465 GLU A 7 REMARK 465 ALA A 8 REMARK 465 PRO A 9 REMARK 465 ARG A 630 REMARK 465 ARG A 631 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 GLU B 3 REMARK 465 GLN B 4 REMARK 465 LEU B 5 REMARK 465 VAL B 6 REMARK 465 GLU B 7 REMARK 465 ALA B 8 REMARK 465 PRO B 9 REMARK 465 ARG B 630 REMARK 465 ARG B 631 REMARK 465 MET C 1 REMARK 465 ALA C 2 REMARK 465 GLU C 3 REMARK 465 GLN C 4 REMARK 465 LEU C 5 REMARK 465 VAL C 6 REMARK 465 GLU C 7 REMARK 465 ALA C 8 REMARK 465 PRO C 9 REMARK 465 ARG C 630 REMARK 465 ARG C 631 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 629 CA C O CB CG CD OE1 REMARK 470 GLU A 629 OE2 REMARK 470 GLU B 629 CA C O CB CG CD OE1 REMARK 470 GLU B 629 OE2 REMARK 470 GLU C 629 CA C O CB CG CD OE1 REMARK 470 GLU C 629 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 33 97.30 -165.72 REMARK 500 SER A 38 -122.99 -147.52 REMARK 500 GLU A 107 143.00 -29.51 REMARK 500 ARG A 158 57.52 -113.93 REMARK 500 ILE A 163 -33.85 -38.26 REMARK 500 GLU A 197 -3.12 -59.04 REMARK 500 GLU A 200 95.01 -57.09 REMARK 500 THR A 201 138.25 -170.65 REMARK 500 LEU A 231 172.64 -59.08 REMARK 500 SER A 257 -156.18 -89.09 REMARK 500 PRO A 263 -79.49 -50.30 REMARK 500 GLN A 344 124.74 -39.34 REMARK 500 ASP A 423 47.26 39.82 REMARK 500 ASN A 430 4.72 -67.70 REMARK 500 TYR A 461 106.63 -57.88 REMARK 500 ASP A 462 -156.94 -87.85 REMARK 500 ASN A 492 -92.18 -155.49 REMARK 500 ILE A 509 156.25 -44.94 REMARK 500 GLU A 513 156.14 -43.68 REMARK 500 ASN A 528 152.79 -46.07 REMARK 500 ASP A 530 -0.29 -57.47 REMARK 500 ALA A 546 91.37 -68.38 REMARK 500 ARG A 568 25.58 -75.71 REMARK 500 GLU A 593 88.08 -158.64 REMARK 500 ALA A 627 1.95 -64.57 REMARK 500 ILE A 628 -71.22 -135.80 REMARK 500 TRP B 33 96.30 -164.65 REMARK 500 SER B 38 -122.28 -146.37 REMARK 500 ARG B 58 -35.91 -39.65 REMARK 500 ARG B 105 -1.96 -56.00 REMARK 500 GLU B 107 132.67 -35.85 REMARK 500 SER B 119 -6.82 -59.68 REMARK 500 ARG B 158 57.06 -114.05 REMARK 500 ILE B 163 -35.70 -39.90 REMARK 500 GLU B 197 -4.17 -57.99 REMARK 500 GLU B 200 97.93 -57.78 REMARK 500 THR B 201 137.90 -173.48 REMARK 500 PRO B 263 -79.02 -50.45 REMARK 500 ALA B 328 -8.40 -54.31 REMARK 500 TYR B 372 58.58 -140.89 REMARK 500 ASP B 423 47.47 39.95 REMARK 500 ASN B 430 4.82 -68.84 REMARK 500 ASN B 492 -92.35 -154.68 REMARK 500 ILE B 509 156.41 -44.13 REMARK 500 GLU B 513 155.44 -44.54 REMARK 500 ASP B 530 3.43 -60.52 REMARK 500 ARG B 568 27.17 -75.97 REMARK 500 GLU B 593 88.73 -158.61 REMARK 500 ALA B 627 3.19 -65.07 REMARK 500 ILE B 628 -71.09 -136.50 REMARK 500 REMARK 500 THIS ENTRY HAS 78 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE C8E A 700 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE R23 A 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE C8E B 700 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE R23 B 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE C8E C 700 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE R23 C 800 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1GSZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A SQUALENE CYCLASE IN COMPLEX WITH THE REMARK 900 POTENTIAL ANTICHOLESTEREMIC DRUG RO48-8071 REMARK 900 RELATED ID: 1H35 RELATED DB: PDB REMARK 900 STRUCTURES OF HUMAN OXIDOSQUALENE CYCLASE INHIBITORS BOUND TO A REMARK 900 HOMOLGOUS ENZYME REMARK 900 RELATED ID: 1H36 RELATED DB: PDB REMARK 900 STRUCTURES OF HUMAN OXIDOSQUALENE CYCLASE INHIBITORS BOUND TO A REMARK 900 HOMOLGOUS ENZYME REMARK 900 RELATED ID: 1H37 RELATED DB: PDB REMARK 900 STRUCTURES OF HUMAN OXIDOSQUALENE CYCLASE INHIBITORS BOUND TO A REMARK 900 HOMOLGOUS ENZYME REMARK 900 RELATED ID: 1H39 RELATED DB: PDB REMARK 900 STRUCTURES OF HUMAN OXIDOSQUALENE CYCLASE INHIBITORS BOUND TO A REMARK 900 HOMOLGOUS ENZYME REMARK 900 RELATED ID: 1H3A RELATED DB: PDB REMARK 900 STRUCTURES OF HUMAN OXIDOSQUALENE CYCLASE INHIBITORS BOUND TO A REMARK 900 HOMOLGOUS ENZYME REMARK 900 RELATED ID: 1H3B RELATED DB: PDB REMARK 900 SQUALENE-HOPENE CYCLASE REMARK 900 RELATED ID: 1H3C RELATED DB: PDB REMARK 900 STRUCTURES OF HUMAN OXIDOSQUALENE CYCLASE INHIBITORS BOUND TO A REMARK 900 HOMOLGOUS ENZYME REMARK 900 RELATED ID: 1O6H RELATED DB: PDB REMARK 900 SQUALENE-HOPENE CYCLASE REMARK 900 RELATED ID: 1O6Q RELATED DB: PDB REMARK 900 STRUCTURES OF HUMAN OXIDOSQUALENE CYCLASE INHIBITORS BOUND TO A REMARK 900 HOMOLGOUS ENZYME REMARK 900 RELATED ID: 1O6R RELATED DB: PDB REMARK 900 STRUCTURES OF HUMAN OXIDOSQUALENE CYCLASE INHIBITORS BOUND TO A REMARK 900 HOMOLGOUS ENZYME REMARK 900 RELATED ID: 1SQC RELATED DB: PDB REMARK 900 SQUALENE-HOPENE-CYCLASE FROM ALICYCLOBACILLUS ACIDOCALDARIUS REMARK 900 RELATED ID: 1UMP RELATED DB: PDB REMARK 900 GEOMETRY OF TRITERPENE CONVERSION TO PENTACARBOCYCLIC HOPENE REMARK 900 RELATED ID: 2SQC RELATED DB: PDB REMARK 900 SQUALENE-HOPENE CYCLASE FROM ALICYCLOBACILLUS ACIDOCALDARIUS REMARK 900 RELATED ID: 3SQC RELATED DB: PDB REMARK 900 SQUALENE-HOPENE CYCLASE DBREF 1O79 A 1 1 PDB 1O79 1O79 1 1 DBREF 1O79 A 2 631 UNP P33247 SQHC_ALIAC 1 630 DBREF 1O79 B 1 1 PDB 1O79 1O79 1 1 DBREF 1O79 B 2 631 UNP P33247 SQHC_ALIAC 1 630 DBREF 1O79 C 1 1 PDB 1O79 1O79 1 1 DBREF 1O79 C 2 631 UNP P33247 SQHC_ALIAC 1 630 SEQRES 1 A 631 MET ALA GLU GLN LEU VAL GLU ALA PRO ALA TYR ALA ARG SEQRES 2 A 631 THR LEU ASP ARG ALA VAL GLU TYR LEU LEU SER CYS GLN SEQRES 3 A 631 LYS ASP GLU GLY TYR TRP TRP GLY PRO LEU LEU SER ASN SEQRES 4 A 631 VAL THR MET GLU ALA GLU TYR VAL LEU LEU CYS HIS ILE SEQRES 5 A 631 LEU ASP ARG VAL ASP ARG ASP ARG MET GLU LYS ILE ARG SEQRES 6 A 631 ARG TYR LEU LEU HIS GLU GLN ARG GLU ASP GLY THR TRP SEQRES 7 A 631 ALA LEU TYR PRO GLY GLY PRO PRO ASP LEU ASP THR THR SEQRES 8 A 631 ILE GLU ALA TYR VAL ALA LEU LYS TYR ILE GLY MET SER SEQRES 9 A 631 ARG ASP GLU GLU PRO MET GLN LYS ALA LEU ARG PHE ILE SEQRES 10 A 631 GLN SER GLN GLY GLY ILE GLU SER SER ARG VAL PHE THR SEQRES 11 A 631 ARG MET TRP LEU ALA LEU VAL GLY GLU TYR PRO TRP GLU SEQRES 12 A 631 LYS VAL PRO MET VAL PRO PRO GLU ILE MET PHE LEU GLY SEQRES 13 A 631 LYS ARG MET PRO LEU ASN ILE TYR GLU PHE GLY SER TRP SEQRES 14 A 631 ALA ARG ALA THR VAL VAL ALA LEU SER ILE VAL MET SER SEQRES 15 A 631 ARG GLN PRO VAL PHE PRO LEU PRO GLU ARG ALA ARG VAL SEQRES 16 A 631 PRO GLU LEU TYR GLU THR ASP VAL PRO PRO ARG ARG ARG SEQRES 17 A 631 GLY ALA LYS GLY GLY GLY GLY TRP ILE PHE ASP ALA LEU SEQRES 18 A 631 ASP ARG ALA LEU HIS GLY TYR GLN LYS LEU SER VAL HIS SEQRES 19 A 631 PRO PHE ARG ARG ALA ALA GLU ILE ARG ALA LEU ASP TRP SEQRES 20 A 631 LEU LEU GLU ARG GLN ALA GLY ASP GLY SER TRP GLY GLY SEQRES 21 A 631 ILE GLN PRO PRO TRP PHE TYR ALA LEU ILE ALA LEU LYS SEQRES 22 A 631 ILE LEU ASP MET THR GLN HIS PRO ALA PHE ILE LYS GLY SEQRES 23 A 631 TRP GLU GLY LEU GLU LEU TYR GLY VAL GLU LEU ASP TYR SEQRES 24 A 631 GLY GLY TRP MET PHE GLN ALA SER ILE SER PRO VAL TRP SEQRES 25 A 631 ASP THR GLY LEU ALA VAL LEU ALA LEU ARG ALA ALA GLY SEQRES 26 A 631 LEU PRO ALA ASP HIS ASP ARG LEU VAL LYS ALA GLY GLU SEQRES 27 A 631 TRP LEU LEU ASP ARG GLN ILE THR VAL PRO GLY ASP TRP SEQRES 28 A 631 ALA VAL LYS ARG PRO ASN LEU LYS PRO GLY GLY PHE ALA SEQRES 29 A 631 PHE GLN PHE ASP ASN VAL TYR TYR PRO ASP VAL ASP ASP SEQRES 30 A 631 THR ALA VAL VAL VAL TRP ALA LEU ASN THR LEU ARG LEU SEQRES 31 A 631 PRO ASP GLU ARG ARG ARG ARG ASP ALA MET THR LYS GLY SEQRES 32 A 631 PHE ARG TRP ILE VAL GLY MET GLN SER SER ASN GLY GLY SEQRES 33 A 631 TRP GLY ALA TYR ASP VAL ASP ASN THR SER ASP LEU PRO SEQRES 34 A 631 ASN HIS ILE PRO PHE CYS ASP PHE GLY GLU VAL THR ASP SEQRES 35 A 631 PRO PRO SER GLU ASP VAL THR ALA HIS VAL LEU GLU CYS SEQRES 36 A 631 PHE GLY SER PHE GLY TYR ASP ASP ALA TRP LYS VAL ILE SEQRES 37 A 631 ARG ARG ALA VAL GLU TYR LEU LYS ARG GLU GLN LYS PRO SEQRES 38 A 631 ASP GLY SER TRP PHE GLY ARG TRP GLY VAL ASN TYR LEU SEQRES 39 A 631 TYR GLY THR GLY ALA VAL VAL SER ALA LEU LYS ALA VAL SEQRES 40 A 631 GLY ILE ASP THR ARG GLU PRO TYR ILE GLN LYS ALA LEU SEQRES 41 A 631 ASP TRP VAL GLU GLN HIS GLN ASN PRO ASP GLY GLY TRP SEQRES 42 A 631 GLY GLU ASP CYS ARG SER TYR GLU ASP PRO ALA TYR ALA SEQRES 43 A 631 GLY LYS GLY ALA SER THR PRO SER GLN THR ALA TRP ALA SEQRES 44 A 631 LEU MET ALA LEU ILE ALA GLY GLY ARG ALA GLU SER GLU SEQRES 45 A 631 ALA ALA ARG ARG GLY VAL GLN TYR LEU VAL GLU THR GLN SEQRES 46 A 631 ARG PRO ASP GLY GLY TRP ASP GLU PRO TYR TYR THR GLY SEQRES 47 A 631 THR GLY PHE PRO GLY ASP PHE TYR LEU GLY TYR THR MET SEQRES 48 A 631 TYR ARG HIS VAL PHE PRO THR LEU ALA LEU GLY ARG TYR SEQRES 49 A 631 LYS GLN ALA ILE GLU ARG ARG SEQRES 1 B 631 MET ALA GLU GLN LEU VAL GLU ALA PRO ALA TYR ALA ARG SEQRES 2 B 631 THR LEU ASP ARG ALA VAL GLU TYR LEU LEU SER CYS GLN SEQRES 3 B 631 LYS ASP GLU GLY TYR TRP TRP GLY PRO LEU LEU SER ASN SEQRES 4 B 631 VAL THR MET GLU ALA GLU TYR VAL LEU LEU CYS HIS ILE SEQRES 5 B 631 LEU ASP ARG VAL ASP ARG ASP ARG MET GLU LYS ILE ARG SEQRES 6 B 631 ARG TYR LEU LEU HIS GLU GLN ARG GLU ASP GLY THR TRP SEQRES 7 B 631 ALA LEU TYR PRO GLY GLY PRO PRO ASP LEU ASP THR THR SEQRES 8 B 631 ILE GLU ALA TYR VAL ALA LEU LYS TYR ILE GLY MET SER SEQRES 9 B 631 ARG ASP GLU GLU PRO MET GLN LYS ALA LEU ARG PHE ILE SEQRES 10 B 631 GLN SER GLN GLY GLY ILE GLU SER SER ARG VAL PHE THR SEQRES 11 B 631 ARG MET TRP LEU ALA LEU VAL GLY GLU TYR PRO TRP GLU SEQRES 12 B 631 LYS VAL PRO MET VAL PRO PRO GLU ILE MET PHE LEU GLY SEQRES 13 B 631 LYS ARG MET PRO LEU ASN ILE TYR GLU PHE GLY SER TRP SEQRES 14 B 631 ALA ARG ALA THR VAL VAL ALA LEU SER ILE VAL MET SER SEQRES 15 B 631 ARG GLN PRO VAL PHE PRO LEU PRO GLU ARG ALA ARG VAL SEQRES 16 B 631 PRO GLU LEU TYR GLU THR ASP VAL PRO PRO ARG ARG ARG SEQRES 17 B 631 GLY ALA LYS GLY GLY GLY GLY TRP ILE PHE ASP ALA LEU SEQRES 18 B 631 ASP ARG ALA LEU HIS GLY TYR GLN LYS LEU SER VAL HIS SEQRES 19 B 631 PRO PHE ARG ARG ALA ALA GLU ILE ARG ALA LEU ASP TRP SEQRES 20 B 631 LEU LEU GLU ARG GLN ALA GLY ASP GLY SER TRP GLY GLY SEQRES 21 B 631 ILE GLN PRO PRO TRP PHE TYR ALA LEU ILE ALA LEU LYS SEQRES 22 B 631 ILE LEU ASP MET THR GLN HIS PRO ALA PHE ILE LYS GLY SEQRES 23 B 631 TRP GLU GLY LEU GLU LEU TYR GLY VAL GLU LEU ASP TYR SEQRES 24 B 631 GLY GLY TRP MET PHE GLN ALA SER ILE SER PRO VAL TRP SEQRES 25 B 631 ASP THR GLY LEU ALA VAL LEU ALA LEU ARG ALA ALA GLY SEQRES 26 B 631 LEU PRO ALA ASP HIS ASP ARG LEU VAL LYS ALA GLY GLU SEQRES 27 B 631 TRP LEU LEU ASP ARG GLN ILE THR VAL PRO GLY ASP TRP SEQRES 28 B 631 ALA VAL LYS ARG PRO ASN LEU LYS PRO GLY GLY PHE ALA SEQRES 29 B 631 PHE GLN PHE ASP ASN VAL TYR TYR PRO ASP VAL ASP ASP SEQRES 30 B 631 THR ALA VAL VAL VAL TRP ALA LEU ASN THR LEU ARG LEU SEQRES 31 B 631 PRO ASP GLU ARG ARG ARG ARG ASP ALA MET THR LYS GLY SEQRES 32 B 631 PHE ARG TRP ILE VAL GLY MET GLN SER SER ASN GLY GLY SEQRES 33 B 631 TRP GLY ALA TYR ASP VAL ASP ASN THR SER ASP LEU PRO SEQRES 34 B 631 ASN HIS ILE PRO PHE CYS ASP PHE GLY GLU VAL THR ASP SEQRES 35 B 631 PRO PRO SER GLU ASP VAL THR ALA HIS VAL LEU GLU CYS SEQRES 36 B 631 PHE GLY SER PHE GLY TYR ASP ASP ALA TRP LYS VAL ILE SEQRES 37 B 631 ARG ARG ALA VAL GLU TYR LEU LYS ARG GLU GLN LYS PRO SEQRES 38 B 631 ASP GLY SER TRP PHE GLY ARG TRP GLY VAL ASN TYR LEU SEQRES 39 B 631 TYR GLY THR GLY ALA VAL VAL SER ALA LEU LYS ALA VAL SEQRES 40 B 631 GLY ILE ASP THR ARG GLU PRO TYR ILE GLN LYS ALA LEU SEQRES 41 B 631 ASP TRP VAL GLU GLN HIS GLN ASN PRO ASP GLY GLY TRP SEQRES 42 B 631 GLY GLU ASP CYS ARG SER TYR GLU ASP PRO ALA TYR ALA SEQRES 43 B 631 GLY LYS GLY ALA SER THR PRO SER GLN THR ALA TRP ALA SEQRES 44 B 631 LEU MET ALA LEU ILE ALA GLY GLY ARG ALA GLU SER GLU SEQRES 45 B 631 ALA ALA ARG ARG GLY VAL GLN TYR LEU VAL GLU THR GLN SEQRES 46 B 631 ARG PRO ASP GLY GLY TRP ASP GLU PRO TYR TYR THR GLY SEQRES 47 B 631 THR GLY PHE PRO GLY ASP PHE TYR LEU GLY TYR THR MET SEQRES 48 B 631 TYR ARG HIS VAL PHE PRO THR LEU ALA LEU GLY ARG TYR SEQRES 49 B 631 LYS GLN ALA ILE GLU ARG ARG SEQRES 1 C 631 MET ALA GLU GLN LEU VAL GLU ALA PRO ALA TYR ALA ARG SEQRES 2 C 631 THR LEU ASP ARG ALA VAL GLU TYR LEU LEU SER CYS GLN SEQRES 3 C 631 LYS ASP GLU GLY TYR TRP TRP GLY PRO LEU LEU SER ASN SEQRES 4 C 631 VAL THR MET GLU ALA GLU TYR VAL LEU LEU CYS HIS ILE SEQRES 5 C 631 LEU ASP ARG VAL ASP ARG ASP ARG MET GLU LYS ILE ARG SEQRES 6 C 631 ARG TYR LEU LEU HIS GLU GLN ARG GLU ASP GLY THR TRP SEQRES 7 C 631 ALA LEU TYR PRO GLY GLY PRO PRO ASP LEU ASP THR THR SEQRES 8 C 631 ILE GLU ALA TYR VAL ALA LEU LYS TYR ILE GLY MET SER SEQRES 9 C 631 ARG ASP GLU GLU PRO MET GLN LYS ALA LEU ARG PHE ILE SEQRES 10 C 631 GLN SER GLN GLY GLY ILE GLU SER SER ARG VAL PHE THR SEQRES 11 C 631 ARG MET TRP LEU ALA LEU VAL GLY GLU TYR PRO TRP GLU SEQRES 12 C 631 LYS VAL PRO MET VAL PRO PRO GLU ILE MET PHE LEU GLY SEQRES 13 C 631 LYS ARG MET PRO LEU ASN ILE TYR GLU PHE GLY SER TRP SEQRES 14 C 631 ALA ARG ALA THR VAL VAL ALA LEU SER ILE VAL MET SER SEQRES 15 C 631 ARG GLN PRO VAL PHE PRO LEU PRO GLU ARG ALA ARG VAL SEQRES 16 C 631 PRO GLU LEU TYR GLU THR ASP VAL PRO PRO ARG ARG ARG SEQRES 17 C 631 GLY ALA LYS GLY GLY GLY GLY TRP ILE PHE ASP ALA LEU SEQRES 18 C 631 ASP ARG ALA LEU HIS GLY TYR GLN LYS LEU SER VAL HIS SEQRES 19 C 631 PRO PHE ARG ARG ALA ALA GLU ILE ARG ALA LEU ASP TRP SEQRES 20 C 631 LEU LEU GLU ARG GLN ALA GLY ASP GLY SER TRP GLY GLY SEQRES 21 C 631 ILE GLN PRO PRO TRP PHE TYR ALA LEU ILE ALA LEU LYS SEQRES 22 C 631 ILE LEU ASP MET THR GLN HIS PRO ALA PHE ILE LYS GLY SEQRES 23 C 631 TRP GLU GLY LEU GLU LEU TYR GLY VAL GLU LEU ASP TYR SEQRES 24 C 631 GLY GLY TRP MET PHE GLN ALA SER ILE SER PRO VAL TRP SEQRES 25 C 631 ASP THR GLY LEU ALA VAL LEU ALA LEU ARG ALA ALA GLY SEQRES 26 C 631 LEU PRO ALA ASP HIS ASP ARG LEU VAL LYS ALA GLY GLU SEQRES 27 C 631 TRP LEU LEU ASP ARG GLN ILE THR VAL PRO GLY ASP TRP SEQRES 28 C 631 ALA VAL LYS ARG PRO ASN LEU LYS PRO GLY GLY PHE ALA SEQRES 29 C 631 PHE GLN PHE ASP ASN VAL TYR TYR PRO ASP VAL ASP ASP SEQRES 30 C 631 THR ALA VAL VAL VAL TRP ALA LEU ASN THR LEU ARG LEU SEQRES 31 C 631 PRO ASP GLU ARG ARG ARG ARG ASP ALA MET THR LYS GLY SEQRES 32 C 631 PHE ARG TRP ILE VAL GLY MET GLN SER SER ASN GLY GLY SEQRES 33 C 631 TRP GLY ALA TYR ASP VAL ASP ASN THR SER ASP LEU PRO SEQRES 34 C 631 ASN HIS ILE PRO PHE CYS ASP PHE GLY GLU VAL THR ASP SEQRES 35 C 631 PRO PRO SER GLU ASP VAL THR ALA HIS VAL LEU GLU CYS SEQRES 36 C 631 PHE GLY SER PHE GLY TYR ASP ASP ALA TRP LYS VAL ILE SEQRES 37 C 631 ARG ARG ALA VAL GLU TYR LEU LYS ARG GLU GLN LYS PRO SEQRES 38 C 631 ASP GLY SER TRP PHE GLY ARG TRP GLY VAL ASN TYR LEU SEQRES 39 C 631 TYR GLY THR GLY ALA VAL VAL SER ALA LEU LYS ALA VAL SEQRES 40 C 631 GLY ILE ASP THR ARG GLU PRO TYR ILE GLN LYS ALA LEU SEQRES 41 C 631 ASP TRP VAL GLU GLN HIS GLN ASN PRO ASP GLY GLY TRP SEQRES 42 C 631 GLY GLU ASP CYS ARG SER TYR GLU ASP PRO ALA TYR ALA SEQRES 43 C 631 GLY LYS GLY ALA SER THR PRO SER GLN THR ALA TRP ALA SEQRES 44 C 631 LEU MET ALA LEU ILE ALA GLY GLY ARG ALA GLU SER GLU SEQRES 45 C 631 ALA ALA ARG ARG GLY VAL GLN TYR LEU VAL GLU THR GLN SEQRES 46 C 631 ARG PRO ASP GLY GLY TRP ASP GLU PRO TYR TYR THR GLY SEQRES 47 C 631 THR GLY PHE PRO GLY ASP PHE TYR LEU GLY TYR THR MET SEQRES 48 C 631 TYR ARG HIS VAL PHE PRO THR LEU ALA LEU GLY ARG TYR SEQRES 49 C 631 LYS GLN ALA ILE GLU ARG ARG HET C8E A 700 21 HET R23 A 800 31 HET C8E B 700 21 HET R23 B 800 31 HET C8E C 700 21 HET R23 C 800 31 HETNAM C8E (HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE HETNAM R23 METHYL-[4-(4-PIPERIDINE-1-YLMETHYL-PHENYL)-CYCLOHEXYL]- HETNAM 2 R23 CARBAMINIC ACID-(4-CHLOROPHENYL)-ESTER FORMUL 4 C8E 3(C16 H34 O5) FORMUL 5 R23 3(C26 H33 CL N2 O2) FORMUL 10 HOH *237(H2 O) HELIX 1 1 ALA A 10 GLN A 26 1 17 HELIX 2 2 VAL A 40 LEU A 53 1 14 HELIX 3 3 ASP A 57 GLN A 72 1 16 HELIX 4 4 ASP A 87 GLY A 102 1 16 HELIX 5 5 GLU A 107 GLN A 120 1 14 HELIX 6 6 GLY A 121 SER A 126 5 6 HELIX 7 7 ARG A 127 VAL A 137 1 11 HELIX 8 8 PRO A 141 VAL A 145 5 5 HELIX 9 9 PRO A 149 LEU A 155 5 7 HELIX 10 10 ASN A 162 PHE A 166 5 5 HELIX 11 11 GLY A 167 GLN A 184 1 18 HELIX 12 12 PRO A 190 ARG A 194 5 5 HELIX 13 13 VAL A 195 TYR A 199 5 5 HELIX 14 14 GLY A 215 GLN A 229 1 15 HELIX 15 15 PHE A 236 GLN A 252 1 17 HELIX 16 16 ILE A 261 LEU A 275 1 15 HELIX 17 17 HIS A 280 GLY A 289 1 10 HELIX 18 18 LEU A 290 LEU A 292 5 3 HELIX 19 19 SER A 309 GLY A 325 1 17 HELIX 20 20 HIS A 330 GLN A 344 1 15 HELIX 21 21 GLY A 349 LYS A 354 5 6 HELIX 22 22 ASP A 374 THR A 387 1 14 HELIX 23 23 ASP A 392 GLY A 409 1 18 HELIX 24 24 LEU A 428 ILE A 432 5 5 HELIX 25 25 SER A 445 GLY A 460 1 16 HELIX 26 26 TRP A 465 GLN A 479 1 15 HELIX 27 27 ASN A 492 VAL A 507 1 16 HELIX 28 28 GLU A 513 GLN A 525 1 13 HELIX 29 29 ASP A 536 GLU A 541 5 6 HELIX 30 30 ASP A 542 ALA A 546 5 5 HELIX 31 31 THR A 552 GLY A 566 1 15 HELIX 32 32 SER A 571 GLN A 585 1 15 HELIX 33 33 MET A 611 ALA A 627 1 17 HELIX 34 34 TYR B 11 GLN B 26 1 16 HELIX 35 35 VAL B 40 LEU B 53 1 14 HELIX 36 36 ASP B 57 GLN B 72 1 16 HELIX 37 37 ASP B 87 GLY B 102 1 16 HELIX 38 38 GLU B 107 SER B 119 1 13 HELIX 39 39 GLN B 120 SER B 126 5 7 HELIX 40 40 ARG B 127 VAL B 137 1 11 HELIX 41 41 PRO B 141 VAL B 145 5 5 HELIX 42 42 PRO B 149 LEU B 155 5 7 HELIX 43 43 ASN B 162 PHE B 166 5 5 HELIX 44 44 GLY B 167 GLN B 184 1 18 HELIX 45 45 PRO B 190 ARG B 194 5 5 HELIX 46 46 VAL B 195 TYR B 199 5 5 HELIX 47 47 GLY B 215 GLN B 229 1 15 HELIX 48 48 PHE B 236 GLN B 252 1 17 HELIX 49 49 ILE B 261 LEU B 275 1 15 HELIX 50 50 HIS B 280 GLY B 289 1 10 HELIX 51 51 LEU B 290 LEU B 292 5 3 HELIX 52 52 SER B 309 GLY B 325 1 17 HELIX 53 53 HIS B 330 GLN B 344 1 15 HELIX 54 54 GLY B 349 LYS B 354 5 6 HELIX 55 55 ASP B 374 ASN B 386 1 13 HELIX 56 56 ASP B 392 MET B 410 1 19 HELIX 57 57 LEU B 428 ILE B 432 5 5 HELIX 58 58 SER B 445 GLY B 460 1 16 HELIX 59 59 TRP B 465 GLN B 479 1 15 HELIX 60 60 ASN B 492 VAL B 507 1 16 HELIX 61 61 GLU B 513 HIS B 526 1 14 HELIX 62 62 ASP B 536 GLU B 541 5 6 HELIX 63 63 ASP B 542 ALA B 546 5 5 HELIX 64 64 THR B 552 GLY B 566 1 15 HELIX 65 65 SER B 571 GLN B 585 1 15 HELIX 66 66 MET B 611 ALA B 627 1 17 HELIX 67 67 TYR C 11 GLN C 26 1 16 HELIX 68 68 VAL C 40 LEU C 53 1 14 HELIX 69 69 ASP C 57 GLN C 72 1 16 HELIX 70 70 ASP C 87 GLY C 102 1 16 HELIX 71 71 GLU C 107 GLN C 120 1 14 HELIX 72 72 GLY C 121 SER C 126 5 6 HELIX 73 73 ARG C 127 VAL C 137 1 11 HELIX 74 74 PRO C 141 VAL C 145 5 5 HELIX 75 75 PRO C 149 LEU C 155 5 7 HELIX 76 76 ASN C 162 PHE C 166 5 5 HELIX 77 77 GLY C 167 GLN C 184 1 18 HELIX 78 78 PRO C 190 ARG C 194 5 5 HELIX 79 79 VAL C 195 TYR C 199 5 5 HELIX 80 80 GLY C 215 GLN C 229 1 15 HELIX 81 81 PHE C 236 ARG C 251 1 16 HELIX 82 82 ILE C 261 LEU C 275 1 15 HELIX 83 83 HIS C 280 GLY C 289 1 10 HELIX 84 84 GLY C 289 TYR C 293 1 5 HELIX 85 85 SER C 309 GLY C 325 1 17 HELIX 86 86 HIS C 330 GLN C 344 1 15 HELIX 87 87 GLY C 349 LYS C 354 5 6 HELIX 88 88 ASP C 374 ASN C 386 1 13 HELIX 89 89 ASP C 392 MET C 410 1 19 HELIX 90 90 LEU C 428 ILE C 432 5 5 HELIX 91 91 SER C 445 GLY C 460 1 16 HELIX 92 92 TRP C 465 GLN C 479 1 15 HELIX 93 93 ASN C 492 VAL C 507 1 16 HELIX 94 94 GLU C 513 GLN C 525 1 13 HELIX 95 95 ASP C 536 GLU C 541 5 6 HELIX 96 96 ASP C 542 ALA C 546 5 5 HELIX 97 97 THR C 552 GLY C 566 1 15 HELIX 98 98 SER C 571 GLN C 585 1 15 HELIX 99 99 MET C 611 ALA C 627 1 17 SHEET 1 AA 3 LEU A 36 LEU A 37 0 SHEET 2 AA 3 PHE A 605 TYR A 609 -1 O GLY A 608 N LEU A 37 SHEET 3 AA 3 GLY A 598 PHE A 601 -1 O GLY A 598 N LEU A 607 SHEET 1 AB 2 GLY A 294 GLU A 296 0 SHEET 2 AB 2 TRP A 302 PHE A 304 -1 O MET A 303 N VAL A 295 SHEET 1 BA 3 LEU B 36 LEU B 37 0 SHEET 2 BA 3 PHE B 605 TYR B 609 -1 O GLY B 608 N LEU B 37 SHEET 3 BA 3 GLY B 598 PHE B 601 -1 O GLY B 598 N LEU B 607 SHEET 1 BB 2 GLY B 294 GLU B 296 0 SHEET 2 BB 2 TRP B 302 PHE B 304 -1 O MET B 303 N VAL B 295 SHEET 1 CA 3 LEU C 36 LEU C 37 0 SHEET 2 CA 3 PHE C 605 TYR C 609 -1 O GLY C 608 N LEU C 37 SHEET 3 CA 3 GLY C 598 PHE C 601 -1 O GLY C 598 N LEU C 607 SHEET 1 CB 2 GLY C 294 GLU C 296 0 SHEET 2 CB 2 TRP C 302 PHE C 304 -1 O MET C 303 N VAL C 295 CISPEP 1 VAL A 491 ASN A 492 0 -0.15 CISPEP 2 VAL B 491 ASN B 492 0 -0.45 CISPEP 3 VAL C 491 ASN C 492 0 0.12 SITE 1 AC1 6 ARG A 251 PRO A 348 GLY A 349 TYR A 371 SITE 2 AC1 6 ARG B 238 ILE B 242 SITE 1 AC2 13 PHE A 129 ALA A 170 ILE A 261 PRO A 263 SITE 2 AC2 13 PHE A 365 ASP A 374 ASP A 377 TYR A 420 SITE 3 AC2 13 PHE A 437 TRP A 489 PHE A 601 TYR A 609 SITE 4 AC2 13 HOH A2078 SITE 1 AC3 10 ARG A 238 GLU A 241 ILE A 242 MET A 277 SITE 2 AC3 10 ARG B 251 PRO B 348 GLY B 349 ASP B 350 SITE 3 AC3 10 VAL B 353 TYR B 371 SITE 1 AC4 14 PHE B 129 ALA B 170 THR B 173 ILE B 261 SITE 2 AC4 14 PRO B 263 PHE B 365 ASP B 374 ASP B 376 SITE 3 AC4 14 ASP B 377 TYR B 420 PHE B 437 PHE B 601 SITE 4 AC4 14 TYR B 609 HOH B2084 SITE 1 AC5 8 ARG C 238 GLU C 241 ILE C 242 ARG C 251 SITE 2 AC5 8 MET C 277 PRO C 348 GLY C 349 TYR C 371 SITE 1 AC6 13 PHE C 129 ALA C 170 THR C 173 ILE C 261 SITE 2 AC6 13 PRO C 263 PHE C 365 ASP C 374 ASP C 376 SITE 3 AC6 13 ASP C 377 TYR C 420 PHE C 437 PHE C 601 SITE 4 AC6 13 TYR C 609 CRYST1 141.289 141.289 245.397 90.00 90.00 120.00 P 32 2 1 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007078 0.004086 0.000000 0.00000 SCALE2 0.000000 0.008173 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004075 0.00000 MTRIX1 1 -0.479920 -0.877310 -0.000730 141.22539 1 MTRIX2 1 0.877310 -0.479920 -0.003430 -5.67247 1 MTRIX3 1 0.002650 -0.002290 0.999990 1.06708 1 MTRIX1 2 -0.533920 0.845450 -0.012060 78.75256 1 MTRIX2 2 -0.845500 -0.533980 -0.002080 121.70016 1 MTRIX3 2 -0.008200 0.009080 0.999930 0.14779 1